Targeting ER-Positive/HER2-Negative Breast Cancer: Clinical Application of New Advances in Community Practice

Download a slideset on managing early- and advanced-stage ER-positive HER2-negative breast cancer and toxicities associated with targeted therapies.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Sanofi Genzyme